Sales dropped sharply in the second quarter, putting pressure on gross margins and sending EBIT back into red numbers. Adjusted for currency effects, sales decreased approximately 10 percent and even a bit more for envelope products. On a more positive note paper prices are now softer. Bong should have a good opportunity to catch up and regain some margins that was lost during the last couple of years.

Read more and download the Research Update:

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.